Edwards Lifesciences Corp (EW)vsInspira Technologies Oxy BHN Ltd (IINN)
EW
Edwards Lifesciences Corp
$85.96
-1.70%
HEALTHCARE · Cap: $49.01B
IINN
Inspira Technologies Oxy BHN Ltd
$2.11
-9.05%
HEALTHCARE · Cap: $18.91M
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 2181042% more annual revenue ($6.30B vs $289,000). EW leads profitability with a 17.4% profit margin vs 0.0%. EW earns a higher WallStSmart Score of 61/100 (C+).
EW
Buy61
out of 100
Grade: C+
IINN
Avoid15
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+68.7%
Fair Value
$253.29
Current Price
$85.96
$167.33 discount
Intrinsic value data unavailable for IINN.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 31.2%
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
16.7% revenue growth
No standout strengths identified
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Negative free cash flow — burning cash
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin, Debt/Equity, Altman Z-Score. Profitability is solid with margins at 17.4% and operating margin at 31.2%. Revenue growth of 16.7% demonstrates continued momentum.
Bull Case : IINN
IINN has a balanced fundamental profile.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 46.0x leaves little room for execution misses.
Bear Case : IINN
The primary concerns for IINN are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
EW profiles as a growth stock while IINN is a value play — different risk/reward profiles.
IINN carries more volatility with a beta of 2.16 — expect wider price swings.
EW is growing revenue faster at 16.7% — sustainability is the question.
IINN generates stronger free cash flow (-10M), providing more financial flexibility.
Bottom Line
EW scores higher overall (61/100 vs 15/100), backed by strong 17.4% margins and 16.7% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Inspira Technologies Oxy BHN Ltd
HEALTHCARE · MEDICAL DEVICES · USA
Inspira Technologies Oxy BHN Ltd., a specialty medical device company, is engaged in the research, development, manufacture and commercialization of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory insufficiency. The company is headquartered in Ra'annana, Israel.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?